Amber Silva

Amber Silva currently serves as Senior Director of Clinical Operations at Roivant Sciences since September 2022. Prior to this role, Amber held various leadership positions at Alector, including Director and Associate Director of Clinical Operations, and worked as Associate Director of Clinical Operations at Vir Biotechnology, Inc. Amber's extensive experience at Gilead Sciences spanned over a decade, where roles included Clinical Program Manager and Clinical Trial Manager, focusing on Phase 1 studies and global Phase 3 studies for HIV-1 indication. Amber began a career at Roche as a Research Associate, contributing to pre-clinical biology for HIV-related IND applications, and started at PPD Discovery, Inc. as a Research Assistant, honing laboratory techniques. Amber earned a Bachelor of Science degree in Cell/Cellular and Molecular Biology from UC Santa Barbara.